ITFI20120164A1 - Nuovi peptidi glicosilati. - Google Patents

Nuovi peptidi glicosilati.

Info

Publication number
ITFI20120164A1
ITFI20120164A1 ITFI20120164A ITFI20120164A1 IT FI20120164 A1 ITFI20120164 A1 IT FI20120164A1 IT FI20120164 A ITFI20120164 A IT FI20120164A IT FI20120164 A1 ITFI20120164 A1 IT FI20120164A1
Authority
IT
Italy
Prior art keywords
glycosylated peptides
new glycosylated
new
pathology
serum
Prior art date
Application number
Other languages
English (en)
Inventor
Felice Claudio De
Joussef Hayek
Francesca Nuti
Anna Maria Papini
Feliciana Real-Fernandez
Paolo Rovero
Giuseppina Sabatino
Caterina Tiberi
Original Assignee
Azienda Ospedaliera Universitaria S Enese 50
Nuti Francesca 8 33
Papini Anna Maria 8 33
Real Fernandez Feliciana 8 33
Rovero Paolo 8 33
Sabatino Giuseppina 8 33
Tiberi Caterina 8 33
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Azienda Ospedaliera Universitaria S Enese 50, Nuti Francesca 8 33, Papini Anna Maria 8 33, Real Fernandez Feliciana 8 33, Rovero Paolo 8 33, Sabatino Giuseppina 8 33, Tiberi Caterina 8 33 filed Critical Azienda Ospedaliera Universitaria S Enese 50
Priority to ITFI20120164 priority Critical patent/ITFI20120164A1/it
Priority to PCT/IB2013/054590 priority patent/WO2013182984A2/en
Publication of ITFI20120164A1 publication Critical patent/ITFI20120164A1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
ITFI20120164 2012-06-05 2012-08-07 Nuovi peptidi glicosilati. ITFI20120164A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITFI20120164 ITFI20120164A1 (it) 2012-06-05 2012-08-07 Nuovi peptidi glicosilati.
PCT/IB2013/054590 WO2013182984A2 (en) 2012-06-05 2013-06-04 Novel glycosylated peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITFI20120107 2012-06-05
ITFI20120164 ITFI20120164A1 (it) 2012-06-05 2012-08-07 Nuovi peptidi glicosilati.

Publications (1)

Publication Number Publication Date
ITFI20120164A1 true ITFI20120164A1 (it) 2013-12-06

Family

ID=46727320

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI20120164 ITFI20120164A1 (it) 2012-06-05 2012-08-07 Nuovi peptidi glicosilati.

Country Status (2)

Country Link
IT (1) ITFI20120164A1 (it)
WO (1) WO2013182984A2 (it)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla

Also Published As

Publication number Publication date
WO2013182984A2 (en) 2013-12-12
WO2013182984A3 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
TN2014000438A1 (en) Anti-fcrn antibodies
EA201400579A1 (ru) Антитела к il-36r
BR112015012014A2 (pt) proteínas de ligação específicas duais penetrando a barreira hematoencefálica (bbb)
NZ730763A (en) Methods of treating a tauopathy
MA34091B1 (fr) Anticorps anti-cd40
MX353482B (es) Metodos para el tratamiento del cancer y enfermedades inflamatorias utilizando cereblon como predictor.
WO2014200910A3 (en) Bioinformatic processes for determination of peptide binding
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
EA201270722A1 (ru) Формы рифаксимина и их применение
BR112014026755B8 (pt) anticorpos contra claudin 18.2 úteis no diagnóstico de câncer
PH12014502406B1 (en) Anti-il-23p19 antibodies
EA201500172A1 (ru) Модифицированные полипептиды фактора х и их применение
DK2594588T3 (da) Anti-Adrenomedullin (ADM)-antistof eller anti-ADM-antistoffragment eller anti-ADM-ikke-Ig-protein-scaffold til anvendelse i terapi
BR112016002401A2 (pt) métodos para reduzir as taxas de exacerbação de asma usando benralizumab
PH12016500753B1 (en) Antibodies specific to fcrn
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
WO2014140362A3 (en) Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(msc)
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
TR201910413T4 (tr) Benralizumab kullanarak astım semptomlarının iyileştirilmesine yönelik yöntemler.
EA201390955A1 (ru) Слитый белок robo1-fc для применения в лечении гепатокарциномы
WO2015001013A3 (en) Human anti-ifn-alpha antibodies
TR201907907T4 (tr) Benralizumab kullanarak astımlı hastalarda zorlu ekspiratuar hacmi arttırma yöntemleri.
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.